For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Jazz Pharmaceuticals, Inc.

USPTO Granted Patents = 28

% Expired Patents = 42.9

EPO Patents = 2

Forward Citations = 1,750

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Clark Patrick Allphin (15 out of 34 patents)

Dayton T Reardan (11 out of 35 patents)

James Frederick Pfeiffer (9 out of 16 patents)

4. Harry Cook (7 out of 10 patents)

5. Martha Hamilton (7 out of 10 patents)

6. Colette Goderstad (7 out of 10 patents)

7. Douglas Willard Danielson (7 out of 12 patents)

8. Patti A Engel (4 out of 7 patents)

9. Bob Gagne (4 out of 8 patents)

10. Andrea Marie Rourke (3 out of 3 patents)

11. Maura Patricia Murphy (3 out of 3 patents)

12. Michael Des Jardin (2 out of 2 patents)

13. Sigridur Olafsdottir (2 out of 3 patents)

14. Gene Curtis Jamieson (2 out of 20 patents)

15. Prasheel Vashdev Lillaney (1 out of 1 patent)

28 patents: Sort by Forward Citations

1. 12161620 - Devices and methods for facilitating and controlling use of a medication (2024-12-10),

2. 11456081 - Sensitive drug distribution systems and methods (2022-09-27),

3. 11207270 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2021-12-28),

4. 11090269 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2021-08-17),

5. 11033530 - Devices and methods for facilitating and controlling use of a medication (2021-06-15),

6. 10987310 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2021-04-27),

7. 10966931 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2021-04-06),

8. 10959956 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2021-03-30),

9. 10813885 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2020-10-27),

10. 10758488 - Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances (2020-09-01),

11. 9801852 - Devices and methods for facilitating and controlling use of a medication (2017-10-31),

12. 9795567 - Immediate release formulations and dosage forms of gamma-hydroxybutyrate (2017-10-24),

13. 9539330 - Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy (2017-01-10),

14. 8952062 - Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy (2015-02-10),

15. 8859619 - Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy (2014-10-14),

Jazz Pharmaceuticals, Inc. is a global biopharmaceutical company dedicated to improving the lives of patients by developing and commercializing innovative products in the areas of neuroscience and oncology. With a diverse portfolio of medicines and a passion for transforming the lives of individuals with severe and complex medical conditions, Jazz Pharmaceuticals strives to make a positive impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Jazz Pharmaceuticals, Inc.

28 Patents

#68 in Palo Alto, CA

#2,839 in California

#11,987 in US

#23,221 in the World

Palo Alto, CA, United States of America

Jazz Pharmaceuticals, Inc.

Forward Citations = 1,750

20 inventors:

Clark Patrick Allphin (15 out of 34 patents)

Dayton T Reardan (11 out of 35 patents)

James Frederick Pfeiffer (9 out of 16 patents)

4. Harry Cook (7 out of 10 patents)

5. Martha Hamilton (7 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…